English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Diabetes mellitus is a growing medical concern. Among patients with coronary artery disease and those with myocardial infarction, the reported prevalence of diabetes ranges between 20 and 40%. Those patients with recognised diabetes mellitus do not, however, constitute the totality of patients presenting with dysglycaemia. Whereas the increased cardiovascular risk specifically related to diabetes in coronary patients is well known and documented, less attention has been given to prediabetes and its interaction with cardiovascular outcomes. In the current issue of EuroIntervention, Kok et al present an analysis of clinical outcomes in a cohort of nearly 3,000 patients after percutaneous coronary intervention (PCI) with implantation of biodegradable or non-degradable polymer drug-eluting stents (DES), according to their glycaemic status1.

What should interventional cardiologists do for patients with prediabetes?